|
US4443442A
(en)
|
1979-12-21 |
1984-04-17 |
Skillern Scott D |
Method and composition for treatment of acne vulgaris
|
|
AU8952282A
(en)
|
1982-08-25 |
1984-03-29 |
Joel E. Bernstein |
Method of treating pruritis and composition therefor
|
|
US4720384A
(en)
|
1985-05-03 |
1988-01-19 |
E. I. Du Pont De Nemours And Company |
Manufacture of hollow fine tubular drug delivery systems
|
|
US20010006967A1
(en)
|
1992-09-21 |
2001-07-05 |
Stanley M. Crain |
Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists
|
|
US6239154B1
(en)
|
1996-03-08 |
2001-05-29 |
Adolor Corporation |
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
ES2236630T3
(es)
|
1996-11-25 |
2005-07-16 |
Toray Industries, Inc. |
Agente antipruritico.
|
|
US6787149B1
(en)
|
1996-12-12 |
2004-09-07 |
El Khoury And Stein Ltd. |
Topical application of opioid analgesic drugs such as morphine
|
|
US6896899B2
(en)
*
|
1996-12-31 |
2005-05-24 |
Antioxidant Pharmaceuticals Corp. |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
US5760023A
(en)
|
1997-07-14 |
1998-06-02 |
Adolor Corporation |
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
|
|
MXPA99011298A
(es)
|
1997-07-14 |
2004-10-28 |
Adolor Corp |
Formulaciones farmaceuticas antiprurito de agonista kappa y metodo para tratar prurito con las mismas.
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6274591B1
(en)
|
1997-11-03 |
2001-08-14 |
Joseph F. Foss |
Use of methylnaltrexone and related compounds
|
|
CA2376596C
(en)
|
1999-06-25 |
2009-10-06 |
Genentech, Inc. |
Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
|
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
|
US6451806B2
(en)
|
1999-09-29 |
2002-09-17 |
Adolor Corporation |
Methods and compositions involving opioids and antagonists thereof
|
|
JP2001163784A
(ja)
|
1999-12-06 |
2001-06-19 |
Toray Ind Inc |
角膜または結膜用止痒剤
|
|
DE19960154A1
(de)
*
|
1999-12-14 |
2001-07-12 |
Lohmann Therapie Syst Lts |
Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
|
|
JP4370683B2
(ja)
|
2000-05-08 |
2009-11-25 |
東レ株式会社 |
そう痒疾患の検査方法
|
|
DE10116978A1
(de)
|
2001-04-05 |
2002-10-10 |
Merck Patent Gmbh |
Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
|
|
ITMI20010907A1
(it)
|
2001-05-02 |
2002-11-02 |
Valpharma Sa |
Impiego di antagonisti oppioidi per la prevenzione ed il controllo degli effetti collaterali prodotti dagli oppioidi
|
|
US20030054030A1
(en)
|
2001-09-13 |
2003-03-20 |
Gary Gordon |
Method and compositions for the treatment of pruritus
|
|
ES2654819T3
(es)
|
2001-10-18 |
2018-02-15 |
Nektar Therapeutics |
Conjugados poliméricos de antagonistas de opioides
|
|
US6703398B2
(en)
|
2001-11-26 |
2004-03-09 |
Oliver Yoa-Pu Hu |
Orally administered analgesic compositions containing nalbuphine
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
HUE032656T2
(en)
|
2002-04-05 |
2017-10-30 |
Euro Celtique Sa |
Pharmaceutical composition containing oxicodone and naloxone
|
|
US20030191147A1
(en)
|
2002-04-09 |
2003-10-09 |
Barry Sherman |
Opioid antagonist compositions and dosage forms
|
|
DE10229842A1
(de)
|
2002-07-03 |
2004-02-05 |
Helmut Prof. Dr. Schmidhammer |
Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
|
|
ES2392525T3
(es)
|
2002-07-15 |
2012-12-11 |
F. Hoffmann-La Roche Ag |
Tratamiento del cáncer con el anticuerpo dirigido contra ErbB2 rhuMAb 2C4
|
|
SI2263691T1
(sl)
|
2002-07-15 |
2012-12-31 |
F. Hoffmann-La Roche Ag |
Zdravljenje raka z rekombinantnim humaniziranim monoklonskim anti-ErbB2 protitelesom 2C4 (rhuMAb 2C4)
|
|
US7381721B2
(en)
|
2003-03-17 |
2008-06-03 |
Adolor Corporation |
Substituted piperidine compounds
|
|
HRP20150037T4
(hr)
|
2003-04-08 |
2022-09-02 |
Progenics Pharmaceuticals, Inc. |
Farmaceutske formulacije koje sadrže metilnaltrekson
|
|
US7459146B2
(en)
|
2003-05-30 |
2008-12-02 |
3M Innovative Properties Company |
Stabilized aerosol dispersions
|
|
DE602004026604D1
(de)
|
2003-09-25 |
2010-05-27 |
Euro Celtique Sa |
Pharmazeutische kombinationen von hydrocodon und naltrexon
|
|
JP4882744B2
(ja)
|
2004-03-30 |
2012-02-22 |
東レ株式会社 |
止痒剤
|
|
EP1763349A2
(en)
|
2004-06-03 |
2007-03-21 |
Jonathan J. Burbaum |
Pharmaceutical compositions for the treatment of pruritus
|
|
US20060063792A1
(en)
|
2004-09-17 |
2006-03-23 |
Adolor Corporation |
Substituted morphinans and methods of their use
|
|
AR057325A1
(es)
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
|
ES2462541T3
(es)
|
2005-06-09 |
2014-05-23 |
Meda Ab |
Método y composición para el tratamiento de trastornos inflamatorios
|
|
US8394812B2
(en)
*
|
2005-08-24 |
2013-03-12 |
Penwest Pharmaceuticals Co. |
Sustained release formulations of nalbuphine
|
|
HUE053838T2
(hu)
*
|
2005-08-24 |
2021-07-28 |
Endo Pharmaceuticals Inc |
Nyújtott felszabadulású nabulfin-készítmények
|
|
JP2009506080A
(ja)
|
2005-08-30 |
2009-02-12 |
クィーンズ ユニバーシティー アット キングストン |
超低用量のα−２−受容体アンタゴニストを用いる、オピオイド受容体アゴニストの治療作用の増強方法および／またはオピオイド受容体アゴニストに対する耐性の阻害方法もしくは逆転方法
|
|
WO2007133816A2
(en)
|
2006-01-10 |
2007-11-22 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
|
|
WO2008024490A2
(en)
|
2006-08-24 |
2008-02-28 |
Theraquest Biosciences, Inc. |
Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use
|
|
JP2008109898A
(ja)
|
2006-10-31 |
2008-05-15 |
Toray Ind Inc |
鎮痒作用を有する化合物のスクリーニング方法
|
|
MX2009005000A
(es)
|
2006-11-10 |
2009-10-12 |
Cara Therapeutics Inc |
Amidas de peptidos sinteticos.
|
|
AU2007352557A1
(en)
|
2006-11-22 |
2008-11-13 |
Progenics Pharmaceuticals, Inc. |
(S)-N-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
|
|
US20080176884A1
(en)
|
2006-11-22 |
2008-07-24 |
Progenics Pharmaceuticals, Inc. |
7,8-Saturated-4,5-Epoxy-Morphinanium Analogs
|
|
EP2099456A2
(en)
|
2006-11-22 |
2009-09-16 |
Progenics Pharmaceuticals, Inc. |
N-oxides of 4,5-epoxy-morphinanium analogs
|
|
US20080207667A1
(en)
*
|
2007-02-23 |
2008-08-28 |
Rhame Robert W |
Use of nalbuphine and related compounds to treat symptoms of respiratory problems
|
|
CL2008000905A1
(es)
|
2007-03-29 |
2008-08-22 |
Progenics Pharm Inc |
Compuestos derivados de morfina, antagonistas del receptor opioide periferico; metodo de preparacion; composicion farmaceutica; y uso para reducir los efectos de la actividad opioide endogena.
|
|
CN101677997B
(zh)
|
2007-03-30 |
2012-05-09 |
泰奥加制药公司 |
用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
|
|
WO2008129000A1
(en)
|
2007-04-20 |
2008-10-30 |
Novartis Ag |
Pyridopyrimidine derivatives and use thereof in the treatment of itch and itch related disorders
|
|
ES2396600T3
(es)
|
2007-04-23 |
2013-02-22 |
Symrise Ag |
Ésteres de polietilenglicol y preparaciones cosméticas y/o dermatológicas
|
|
WO2009000878A1
(en)
|
2007-06-28 |
2008-12-31 |
Novartis Ag |
Kallikrein 7 modulators
|
|
EP2197427A2
(en)
|
2007-09-04 |
2010-06-23 |
Alpharma, Inc. |
A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer
|
|
US20090093509A1
(en)
|
2007-10-08 |
2009-04-09 |
Tahir Nazir |
Methods and Compositions for the Treatment of Pruritus
|
|
US20110112129A2
(en)
|
2007-11-26 |
2011-05-12 |
Pharmacofore, Inc. |
Peripheral Phenolic Opioid Antagonist
|
|
WO2009103004A1
(en)
|
2008-02-14 |
2009-08-20 |
Alkermes, Inc. |
Selective opioid compounds
|
|
US8686040B2
(en)
|
2008-03-31 |
2014-04-01 |
Rdd Pharma Ltd. |
Method for treating anal pruritis and other perianal disorders
|
|
WO2009132313A2
(en)
|
2008-04-25 |
2009-10-29 |
Progenics Pharmaceuticals, Inc. |
Morphinan derivatives of organic and inorganic acids
|
|
US20110262446A1
(en)
*
|
2008-10-14 |
2011-10-27 |
Dyax Corp. |
Use of igf-ii/igf-iie binding proteins for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis
|
|
EA201101207A1
(ru)
|
2009-02-24 |
2012-04-30 |
Новартис Аг |
Применение антагонистов рецептора nk
|
|
US20100227876A1
(en)
|
2009-03-06 |
2010-09-09 |
Rechfensen Llp |
Methods of Reducing Side Effects of Analgesics
|
|
EP3170395A1
(en)
|
2009-03-19 |
2017-05-24 |
Alkermes Pharma Ireland Limited |
Morphinan derivatives with high oral bioavailability
|
|
AU2010238925A1
(en)
|
2009-04-22 |
2011-12-15 |
Phoeme Gmbh |
Particulate pharmaceutical composition having an opioid and an opioid antagonist
|
|
GB201111485D0
(en)
*
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
US9364623B2
(en)
*
|
2009-07-15 |
2016-06-14 |
UNIVERSITé LAVAL |
Method and device for administering oxygen to a patient and monitoring the patient
|
|
AU2011211223B2
(en)
|
2010-01-29 |
2014-10-23 |
Toray Industries, Inc. |
Therapeutic or prophylactic agent for biliary diseases
|
|
IT1398930B1
(it)
|
2010-03-24 |
2013-03-28 |
Molteni & C |
Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi.
|
|
FR2963889B1
(fr)
*
|
2010-08-20 |
2013-04-12 |
Debregeas Et Associes Pharma |
Formulations a base de nalbuphine et leurs utilisations
|
|
JP2012087101A
(ja)
|
2010-10-21 |
2012-05-10 |
Holger Hermann Lars |
オピオイドおよびオピオイド拮抗薬を含む微粒子医薬組成物
|
|
US8637538B1
(en)
|
2012-12-14 |
2014-01-28 |
Trevi Therapeutics, Inc. |
Methods for treatment of pruritis
|
|
US8987289B2
(en)
|
2012-12-14 |
2015-03-24 |
Trevi Therapeutics, Inc. |
Methods for treating pruritus
|
|
ES2984559T3
(es)
|
2012-12-14 |
2024-10-29 |
Trevi Therapeutics Inc |
Métodos de tratamiento del prurito
|
|
US20140179727A1
(en)
|
2012-12-14 |
2014-06-26 |
Trevi Therapeutics, Inc. |
Methods for treating pruritus
|
|
RU2650118C2
(ru)
*
|
2013-08-23 |
2018-04-09 |
Афферент Фармасьютикалз Инк. |
Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться
|
|
MX2016016404A
(es)
|
2014-06-13 |
2017-11-30 |
Trevi Therapeutics Inc |
Metodos para el tratamiento del prurito.
|
|
WO2017108917A1
(en)
*
|
2015-12-22 |
2017-06-29 |
Astrazeneca Ab |
Pharmaceutical compositions for use in the treatment of chronic obstructive pulmonary disease
|
|
CA3008920C
(en)
*
|
2015-12-23 |
2024-09-17 |
Conrig Pharma Aps |
SUPLATAST TOSILATE FOR THE TREATMENT OF COUGH ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
|
|
WO2017120468A1
(en)
|
2016-01-06 |
2017-07-13 |
Trevi Therapeutics, Inc. |
Therapeutic use of nalbuphine without aquaretic effects
|
|
RS59313B1
(sr)
*
|
2016-01-08 |
2019-10-31 |
Nerre Therapeutics Ltd |
Orvepitant za lečenje hroničnog kašlja
|
|
CN105560202B
(zh)
|
2016-03-11 |
2019-05-24 |
广州玻思韬控释药业有限公司 |
一种盐酸纳布啡凝胶骨架缓释片的制备方法及应用
|
|
CN109310656A
(zh)
|
2016-03-21 |
2019-02-05 |
特雷维治疗股份有限公司 |
尿毒症性瘙痒症的治疗
|
|
CN109475626A
(zh)
*
|
2016-07-14 |
2019-03-15 |
儿童医院医疗中心 |
治疗纤维化的方法
|
|
EP3506893A4
(en)
*
|
2016-08-31 |
2020-01-22 |
Respivant Sciences GmbH |
CROMOLYN COMPOSITIONS FOR THE TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONAL FIBROSIS
|
|
MX2019004804A
(es)
|
2016-10-25 |
2019-08-22 |
Trevi Therapeutics Inc |
Tratamiento para el prurigo nodula.
|
|
AU2019301134A1
(en)
|
2018-07-11 |
2021-01-21 |
Trevi Therapeutics, Inc. |
Treatment of the pruritic symptoms of liver disease
|
|
JP2021531299A
(ja)
|
2018-07-23 |
2021-11-18 |
トレビ セラピューティクス インコーポレイテッド |
慢性咳嗽、息切れ、及び呼吸困難の治療
|